Johnson Chemical Pharmaceutical Works Balance Sheet Health
Financial Health criteria checks 5/6
Johnson Chemical Pharmaceutical Works has a total shareholder equity of NT$1.7B and total debt of NT$160.8M, which brings its debt-to-equity ratio to 9.6%. Its total assets and total liabilities are NT$2.0B and NT$321.0M respectively. Johnson Chemical Pharmaceutical Works's EBIT is NT$98.8M making its interest coverage ratio -56.9. It has cash and short-term investments of NT$1.1B.
Key information
9.6%
Debt to equity ratio
NT$160.83m
Debt
| Interest coverage ratio | -56.9x |
| Cash | NT$1.09b |
| Equity | NT$1.67b |
| Total liabilities | NT$320.99m |
| Total assets | NT$1.99b |
Recent financial health updates
Recent updates
Could Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Have The Makings Of Another Dividend Aristocrat?
Mar 25
These 4 Measures Indicate That Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Using Debt Reasonably Well
Feb 18Weak Financial Prospects Seem To Be Dragging Down Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Stock
Feb 01Estimating The Fair Value Of Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747)
Jan 12
Is Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) An Attractive Dividend Stock?
Dec 25Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Growing Earnings But Are They A Good Guide?
Dec 07Financial Position Analysis
Short Term Liabilities: 4747's short term assets (NT$1.4B) exceed its short term liabilities (NT$220.0M).
Long Term Liabilities: 4747's short term assets (NT$1.4B) exceed its long term liabilities (NT$101.0M).
Debt to Equity History and Analysis
Debt Level: 4747 has more cash than its total debt.
Reducing Debt: 4747's debt to equity ratio has increased from 0% to 9.6% over the past 5 years.
Debt Coverage: 4747's debt is well covered by operating cash flow (85.2%).
Interest Coverage: 4747 earns more interest than it pays, so coverage of interest payments is not a concern.